Evolus, Inc.
EOLS
株式のランク
#12986
Evolus, Inc. is a performance beauty enterprise that furnishes the United... Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.
株価
$7.49
時価総額
$494.72M
変化（1日）
1.22%
変化（1年）
-48.63%
国
US
取引 Evolus, Inc. (EOLS)
カテゴリー
Healthcare
Evolus, Inc.（EOLS）の株価履歴
終値の最高値: $12.39 （2025-01-01）
終値の最安値: $19.84 （2018-08-01）
終値の最安値: $19.84 （2018-08-01）
Evolus, Inc. の株価履歴（2018 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2025 | 3.66% |
| 2024 | 20.62% |
| 2023 | 39.40% |
| 2022 | 15.12% |
| 2021 | -56.66% |
| 2019 | -3.72% |
| 2018 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $164.80 | 23.25% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $226.93 | 32.52% |
CH
|
|
| $18.43 | -4.03% |
IN
|
